CECR2 is an epigenetic driver of breast cancer metastasis, and inhibiting the protein prevented metastases in mouse models, researchers say.
Reuters Health Information
CECR2 is an epigenetic driver of breast cancer metastasis, and inhibiting the protein prevented metastases in mouse models, researchers say.
Reuters Health Information